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Female genital mutilation (FGM/C), has no health benefits, it violates human rights and 
has adverse health (physical, psychological, sexual, maternal and child health), and 
social consequences 1, 2. Globally, over 200 million women have been cut and are living 
with FGM/C-related consequences 3, 4. In Africa, it is estimated that 27 million, 24 million 
and 20 million girls/women have undergone FGM/C in Egypt, Ethiopia and Nigeria 
respectively, making them the countries with the highest prevalence of FGM/C on the 
continent 5. In Nigeria, although the practice is considered widespread, national surveys 
suggest a gradual decline of FGM/C prevalence among women aged 15 – 49 years 
30% in 2008 to 20% in 2018 6,7.  While these statistics suggest progress, the prevalence 
is, however, is still as high as 67% in some states8. Despite the existence of laws, 
policies and a plan of action that should drive the health system’s response to 
prevention and management of FGM/C, the practice persists. Nigeria’s National 
Strategic Health Development Plan Framework (2009- 2015) highlighted the need to 
strengthen the health system to cater for an increasing population served by scarce 
skilled health professionals. The extent of preparedness of health facilities (primary, 
secondary and tertiary) to prevent and manage complications of FGM/C is poorly 
understood.  
 
RESEARCH METHODS AND QUESTIONS  
A qualitative approach as well as a health facility assessment was undertaken to 
understand the health system’s response to the management and prevention of FGM/C 
in Imo state. In-depth interviews, focus group discussions, clinical meetings among 
service providers, key informant interviews and stakeholder dialogues (national and 
state level) were used. A health facility assessment was also conducted to examine 
service delivery levels. The study explored how the health system implements the 
national policy and plan of action for FGM/C and how the health care sector supports 
the prevention and management of FGM/C-related complications to identify possible 
solutions for systems strengthening.  Descriptive statistics were used to summarise 
survey data and qualitative interviews were digitally recorded, transcribed and analysed 
using NVIVO 12 software. Thematic analysis was used to explore emergent patterns 
and themes within the data. Ethical approval was obtained from Imo State Ministry of 
Health and from Population Council’s Institutional Review Board (IRB).  
The main questions researchers sought to answer were: 
• How is the health sector responding to existing FGM/C-related laws and policies? 
• What role is the health care sector playing in the prevention of FGM/C? 
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Findings from this study show that the level of readiness of the health 
facilities to handle FGM/C-related complications is low as evidenced by poor 
infrastructure, lack of equipment and limited human capacity.  
 
Improving the health system response in the prevention and management 
of FGM/C complications requires focused funding, political leadership and 
better stakeholder coordination. 
 
• What are contextual stakeholders supporting or 
inhibiting the health sector’s response to FGM/C?  
• What is the availability, content, and quality of 
FGM/C-related service provision? 
• How is the health sector catering to the needs of 
women/girls who have undergone FGM/C? 
  
WHAT THE EVIDENCE SHOWS: 
• Leadership and governance: Limited political 
will and lack of intersectoral collaboration across 
different layers of government actors resulted in 
poor ownership and implementation of the policies 
and action plans related to the elimination of 
FGM/C. The role of government in leadership and 
coordination of FGM/C activities has been further 
limited by funding gaps within the state.  
• Service readiness: FGM/C awareness and 
prevention services were high at the community 
level, but the overall level of preparedness of  
health facilities to respond to FGM/C related 
complications was relatively low as evidenced by 
poor infrastructure, lack of equipment and poor 
human capacity.  
• Budgeting and funding for FGM/C activities: 
Serious funding gaps were identified at two levels 
main levels - poor budgetary provision and poor 
disbursement. These gaps affect policy 
dissemination, implementation, and domestication 
at both the Federal and State levels. The reliance 
on donor-funding for projects has skewed 
implementation in favour of donor-priority states 
and donor-focused activities.   
• Health workforce: There are an inadequate 
number of skilled personnel to provide FGM/C-
specific prevention services and management of 
complications. The few available personnel have 
a limited understanding of treatment and 
management of FGM/c complications.  
• Health information system: FGM/C is not 
documented at health facilities and as a result, 
incidence and prevalence data are almost non-
existent. This is due to inadequate manpower to 
capture records, the absence of a column in the 
facility register to capture FGM/C status, and poor 
knowledge among health workers on the 
importance. 
• Availability of medicines, equipment, and 
supplies: Medicines, equipment and supplies 
were inadequate at health facilities. Although this 
gap is primarily attributable to poor funding, 
additional factors include weak systems for 
monitoring/maintaining materials, equipment and 




To strengthen the health system response to FGM/C in 
Nigeria, we recommend that: 
• There should be improved data management 
systems for FGM/C at the facility and community 
level to help the government better understand the 
levels of FGM/C.  
• The government should demonstrate financial 
commitment and ensure transition and ownership of 
activities beyond the tenure of FGM/C projects. This 
would strengthen the ownership, coordination and 
the role of government in the FGM response as well 
as improve sustainability of FGM/C programs.  
• Health workers should be properly trained and 
sensitized on the WHO guidelines on management 
of FGM/C complications to improve their capacity to 
respond.  
• Research should be commissioned to explore client 
satisfaction, quality of care and management of 
FGM/C complications.  
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